Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA-Approved Nasal Spray For Depression Is 1st Of Its Kind
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
4d
on MSN
Nasal spray approved to help treat depression
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.
1d
How cinema helped villainise the bald man
In his new action movie ‘Flight Risk’, Mark Wahlberg plays a villain – and you can tell because his character is balding.
Daily Journal
2d
Doctors testify to mental fitness on final day of Urmeyville murder trial
The trial of a rural Franklin woman who claimed she is God and the man she killed is Satan concluded Thursday.
BioSpace
3d
J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy
On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...
3d
Seniors who are children of divorce face greater stroke risk, study finds
Seniors have a 61% higher risk of stroke if their parents divorced when they were children or teenagers, researchers reported in a study published Wednesday in the journal PLOS One.
1d
on MSN
Loretta Ford, co-founder of nurse practitioners, dies at 104
Amid resistance within the medical community, she helped transform the way millions of Americans receive their health care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback